Log in to save to my catalogue

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A sy...

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A sy...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_377409

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review

About this item

Full title

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Journal title

Hepatology communications, 2017-07, Vol.1 (5), p.379-390

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

More information

Scope and Contents

Contents

The significance of the clinical impact of direct‐acting antiviral (DAA) resistance‐associated substitutions (RASs) in hepatitis C virus (HCV) on treatment failure is unclear. No standardized methods or guidelines for detection of DAA RASs in HCV exist. To facilitate further evaluations of the impact of DAA RASs in HCV, we conducted a systematic re...

Alternative Titles

Full title

Sequencing of hepatitis C virus for detection of resistance to direct‐acting antiviral therapy: A systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_uu_377409

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_377409

Other Identifiers

ISSN

2471-254X

E-ISSN

2471-254X

DOI

10.1002/hep4.1050

How to access this item